Vitamin D :: Explore vitamin D’s benefits beyond bones
National Osteoporosis Month is right around the corner, reminding most health professionals to counsel their clients about the bone-building benefits of calcium and vitamin D.
Medical
Diabetes :: Complex genetic risk factors behind type 2 diabetes
A UK collaboration of scientists has identified three new genes that predispose individuals to develop type 2 diabetes 1, bringing scientists a step closer towards understanding what causes this complex disease.
Pharmaceutical :: Drug company sales visits influenced doctors
Almost half of sales visits by pharmaceutical company representatives advocating the use of the drug gabapentin led to doctors stating that they intended to increase their prescription of the drug or recommend it to colleagues, according to an analysis of a survey completed by the doctors shortly after the visits.
Arthritis :: Economic impact of arthritis on United States
Arthritis and other rheumatic conditions exact a large and growing economic toll on the nation as a result of the increase in numbers of persons affected, rather than an increase in mean expenditures and earnings losses, attests Charles G. Helmick, M.D., at the National Center for Chronic Disease Prevention and Health Promotion of the Centers for Disease Control and Prevention.
Heart Attack :: Health Canada approves Lipitor to reduce heart attack risk in coronary heart disease patients
Pfizer Canada Inc. announced that Health Canada has approved the cholesterol-lowering therapy Lipitor(R) (atorvastatin calcium) to reduce the risk of myocardial infarction in patients with clinically evident coronary heart disease.
Heart Disease :: Aspirin may be less effective heart treatment for women than men
A new study shows that aspirin therapy for coronary artery disease is four times more likely to be ineffective in women compared to men with the same medical history.
Vitamin C :: Understanding how plants make vitamin C
Vitamin C is possibly the most important small molecule whose biosynthetic pathway remained a mystery. That is until now. A group of Dartmouth and UCLA researchers, who normally work on genes involved in aging and cancer in animals, discovered the last piece of the puzzle, they report in a study published online April 26 in the Journal of Biological Chemistry.
Eating Disorder :: Scientists, model call on fashion industry to shape up
Scientists and a former supermodel are joining forces to promote healthier practices within the fashion industry as part of the Academy for Eating Disorders (AED) international conference in Baltimore, Maryland, May 2-5, 2007.
Atrial Fibrillation :: Solvay’s Tedisamil for treatment of atrial fibrillation and atrial flutter
Solvay announced that its dossier for intravenous tedisamil (intended brand name: PULZIUM? IV), a new chemical entity coming from Solvay Pharmaceuticals R&D laboratories, has been filed for approval by the US Food and Drug Administration (FDA) as well as by the authorities of European U nion countries.
Crohn’s Disease :: Abbott’s Humira for treatment of Crohn’s disease
Abbott announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), granted a positive opinion recommending approval of HUMIRA? (adalimumab) for the treatment of severe Crohn’s disease.